Search and Filter
Results per Page:
Sabah Öney joins Fred Hutch Board of Directors
President and chief executive officer of Dispatch Bio brings expertise in biotechnology leadership and innovation
HIV/AIDS research has saved millions of lives globally and led to innovative advances in multiple diseases
Numerous medical advances originate from U.S.-funded HIV research
Experts urge clinical trials network to study infectious disease therapies in immunocompromised patients
More than 6% of Americans are immunocompromised, yet most clinical trials exclude them
Patients’ own autoantibodies may hold key to boosting cancer immunotherapy response
A study published in Nature finds that some cancer patients can make their “own companion drug,” suggesting a potential template for future treatments
Fred Hutch Cancer Center clinic to be named in honor of Stuart and Molly Sloan for generous gift totaling $100 million
Stuart and Molly Sloan add to their 2022 transformational gift to boost their impact on research and care
Fred Hutch leads new Vanguard Study for Cancer Screening Research Network
Study aims to understand the effectiveness and use of multi-cancer detection blood tests
Fred Hutch names Board of Directors' leadership, adds new board member
Current board members Ric Anderson and Eduardo Peñalver take on new leadership roles, Jim Lico joins Board of Directors
Fred Hutch announces eight recipients of 2025 Dr. Eddie Méndez Scholar Award
National award honors exceptional postdoctoral researchers in the areas of cancer, infectious disease and basic science